MapLight Therapeutics to Participate in Upcoming Investor Conferences
MapLight Therapeutics, a clinical-stage biopharmaceutical company specializing in central nervous system disorders, announced its management team's participation in the 2026 RBCCM Global Healthcare Conference and the 2026 Jefferies Global Healthcare Conference. The company focuses on developing circuit-specific pharmacotherapies using a novel disco…